000			02279 a2200697 4500
005			20250516180852.0
264		0	_c20141103
008			201411s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2013.170 _2doi
040			_aNLM _beng _cNLM
100	1		_aFox, C P
245	0	0	_aEBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. _h[electronic resource]
260			_bBone marrow transplantation _cFeb 2014
300			_a280-6 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aEpstein-Barr Virus Infections _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aImmunotherapy
650	0	4	_aLymphoproliferative Disorders _xvirology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aViral Load
700	1		_aBurns, D
700	1		_aParker, A N
700	1		_aPeggs, K S
700	1		_aHarvey, C M
700	1		_aNatarajan, S
700	1		_aMarks, D I
700	1		_aJackson, B
700	1		_aChakupurakal, G
700	1		_aDennis, M
700	1		_aLim, Z
700	1		_aCook, G
700	1		_aCarpenter, B
700	1		_aPettitt, A R
700	1		_aMathew, S
700	1		_aConnelly-Smith, L
700	1		_aYin, J A L
700	1		_aViskaduraki, M
700	1		_aChakraverty, R
700	1		_aOrchard, K
700	1		_aShaw, B E
700	1		_aByrne, J L
700	1		_aBrookes, C
700	1		_aCraddock, C F
700	1		_aChaganti, S
773	0		_tBone marrow transplantation _gvol. 49 _gno. 2 _gp. 280-6
856	4	0	_uhttps://doi.org/10.1038/bmt.2013.170 _zAvailable from publisher's website
999			_c23248842 _d23248842